The Wall Street Journal reports a mismatch between Oura's own valuation and investor perceptions of single-product consumer companies, which typically underperform compared to platform models. Oura attempted to defend its position with 20%+ recurring subscription revenue and target gross margins exceeding 55%. The delay is part of a larger cooling in the market, with 7 companies including Holtec Nuclear, Amaero and Bamboo Insurance pulling or delaying deals of $50 million or more in the third quarter.
